Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apo-E genotypes and cardiovascular diseases: a sensitivity study using cross-validatory criteria.

Mark E Glickman1, Mei-Fang Kao

  • 1Department of Health Services, Boston University School of Public Health, USA. mg@bu.edu

Biometrical Journal. Biometrische Zeitschrift
|September 16, 2005
PubMed
Summary

The Apolipoprotein-E (Apo-E) gene influences cardiovascular disease onset age. This study extends a statistical framework to analyze Apo-E genotypes and their impact on cardiovascular disease timing in the Framingham Heart Study cohort.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening.

American journal of respiratory and critical care medicine·2023
Same author

Factors Associated With Declining Lung Cancer Screening After Discussion With a Physician in a Cohort of US Veterans.

JAMA network open·2022
Same author

Invasive Procedures and Associated Complications After Initial Lung Cancer Screening in a National Cohort of Veterans.

Chest·2022
Same author

Inferring medication adherence from time-varying health measures.

Statistics in medicine·2022
Same author

Adherence to Follow-up Testing Recommendations in US Veterans Screened for Lung Cancer, 2015-2019.

JAMA network open·2021
Same author

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease.

Pulmonary circulation·2021

Area of Science:

  • Genetics
  • Epidemiology
  • Biostatistics

Background:

  • The Apolipoprotein-E (Apo-E) gene plays a crucial role in regulating blood lipid levels, making it a key area of interest for cardiovascular disease research.
  • Existing statistical frameworks for analyzing genetic effects on disease onset ages often struggle with censored data and missing genetic information.
  • The Glickman and Gagnon (2002) framework provides a method to infer genetic effects on disease onset while accounting for censoring and missing genetic data.

Purpose of the Study:

  • To apply and extend the Glickman and Gagnon (2002) statistical framework to the Framingham Heart Study cohort.
  • To investigate the effects of different Apolipoprotein-E (Apo-E) genotypes on the onset age of various cardiovascular disease events.
  • To compare different modeling approaches, including univariate versus multivariate onset age components and the incorporation of health covariates.

Related Experiment Videos

Main Methods:

  • Extension of the Glickman and Gagnon (2002) statistical framework for survival analysis.
  • Application to the Framingham Heart Study cohort, including individuals with and without genetic data.
  • Comparison of model fits considering different covariate inclusion strategies (baseline vs. later measurements) and assumptions about Apo-E genotype frequency heritability.

Main Results:

  • The study presents the results from the best-fitting statistical model derived from the extended framework.
  • Analysis focused on the association between Apolipoprotein-E (Apo-E) genotypes and the timing of cardiovascular disease onset.
  • Evaluation of the impact of different modeling choices on the observed genetic effects.

Conclusions:

  • The extended statistical framework successfully analyzes the impact of Apolipoprotein-E (Apo-E) genotypes on cardiovascular disease onset age within the Framingham Heart Study.
  • The findings contribute to understanding the genetic underpinnings of cardiovascular disease risk and timing.
  • The study highlights the importance of robust statistical methods for handling complex genetic and survival data in epidemiological research.